Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
PositiveID (OTC😛SID) put the finishing touches on a first-in-class fully synthetic glucose sensing system, a critical component of its ongoing efforts toward developing an artificial pancreas for people with diabetes.
The company's prototype, developed in partnership with Receptors LLC, can now sense and respond to glucose in human plasma, where it had previously only been demonstrated in a model blood plasma matrix.
The new system is a "mission-critical" component of PositiveID's GlucoChip device, an implantable glucose-sensing microchip.
http://www.massdevice.com/news/diab...toward-artificial-pancreas-massdevicecom-call
The company's prototype, developed in partnership with Receptors LLC, can now sense and respond to glucose in human plasma, where it had previously only been demonstrated in a model blood plasma matrix.
The new system is a "mission-critical" component of PositiveID's GlucoChip device, an implantable glucose-sensing microchip.
http://www.massdevice.com/news/diab...toward-artificial-pancreas-massdevicecom-call